Maxell, Ltd.
Financial Summary for the Fiscal Year Ending March 2026 | Dated April 27, 2026
Maxell's consolidated financial results for the fiscal year ending March 2026 show net sales of ¥129,429 million and net income of ¥8,260 million, representing a 202% increase YoY. Operating profit also surged to ¥8,260 million. Segment-wise, sales growth and improved profitability were achieved in energy and functional materials, with a positive outlook for the future.
Key Figures
- Net Sales: ¥129,429 million (YoY +0.3%)
- Operating Profit: ¥8,260 million (YoY +202%)
- Net Income: ¥8,260 million (YoY +202%)
AI要約
Overview of Financial Performance
Maxell's consolidated financial results for the fiscal year ending March 2026 show net sales of ¥129,429 million (up 0.3% YoY), operating profit of ¥8,260 million (up 202%), and net income of ¥8,260 million (up 202% YoY). The favorable performance of medical devices and infrastructure-related businesses significantly improved sales and profitability. Notably, increased sales of energy and functional materials contributed to the enhanced profitability.
Future Outlook and Impact on Investors
Despite continued uncertainties in the global economy, the company aims to strengthen its earnings base through portfolio reforms and new business initiatives. The earnings forecast for the fiscal year ending March 2027 projects net sales of ¥143,000 million and net income of ¥6,700 million. For investors, the improvement in profitability and diversification of business lines suggest potential for long-term growth.
Maxell, Ltd.
Company overview · Stock price · Financial data · All IR
